Catalyst Wire Dossier Catalyst Wire Dossier

H5N1 Virus-Like Particle Vaccine

virus-like particle vaccine against H5N1 influenza · Novavax, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H5N1 Virus-Like Particle Vaccine, covering 2013-06-21 to 2013-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Reactogenicity and Immunogenicity of an H5N1 VLP [Phase 1, Phase 2]

See pricing